Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

NCT00832494 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: DMXAA in combination with carboplatin and paclitaxel

Sponsor

Antisoma Research